Abstract
Introduction: The left dorsolateral prefrontal cortex (lDLPFC) is a commonly targeted brain region for repetitive transcranial magnetic stimulation (rTMS) for depression. The lDLPFC has been identified using the “5-cm rule.” However, identification of the lDLPFC may deviate from the ideal stimulation site localized by neuronavigation. Therefore, we aimed to compare this method with other methods and examine the relationship between deviation from the ideal stimulation site and treatment effects. While most existing studies have focused on participants of European descent, this study focused on Japanese participants. Methods: The study participants were 16 patients who underwent rTMS and had the stimulus location identified using the 5-cm method. The lDLPFC was identified by the F3 electrode position and neuronavigation in addition to the 5-cm rule, and these locations were compared. We then performed a correlation analysis of the distance between the sites identified by the 5-cm method and by neuronavigation, as well as changes in scores on the 17-item Hamilton Depression Scale (HAMD-17). Results: The lDLPFC identified by the F3 site and neuronavigation was approximately 3 cm more anterolateral than that identified by the 5-cm method. A significant correlation was found between the distance between the sites identified by the 5-cm method and neuronavigation and the rate of change in HAMD-17 scores. Conclusion: The ideal stimulation site may be approximately 3 cm anterior to the site identified by the 5-cm method, and stimulation of the F3 site may be a valid alternative to the 5-cm method.
Journal Section:
Research Article
References
1.
GBD 2019 Diseases and Injuries Collaborators
. Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019
. Lancet
. 2020
;396
(10258
):1204
–22
. 2.
Kessler
RC
, Berglund
P
, Borges
G
, Nock
M
, Wang
PS
. Trends in suicide ideation, plans, gestures, and attempts in the United States, 1990-1992 to 2001-2003
. JAMA
. 2005
;293
(20
):2487
–95
. 3.
Neeleman
J
. A continuum of premature death. Meta-analysis of competing mortality in the psychosocially vulnerable
. Int J Epidemiol
. 2001
;30
(1
):154
–62
. 4.
Nock
MK
, Hwang
I
, Sampson
NA
, Kessler
RC
. Mental disorders, comorbidity and suicidal behavior: results from the National Comorbidity Survey Replication
. Mol Psychiatry
. 2010
;15
(8
):868
–76
. 5.
Foster
T
, Gillespie
K
, McClelland
R
, Patterson
C
. Risk factors for suicide independent of DSM-III-R Axis I disorder. Case-control psychological autopsy study in Northern Ireland
. Br J Psychiatry
. 1999
;175
:175
–9
. 6.
Vijayakumar
L
, Rajkumar
S
. Are risk factors for suicide universal? A case-control study in India
. Acta Psychiatr Scand
. 1999
;99
(6
):407
–11
. 7.
Practice guideline for the treatment of patients with major depressive disorder (revision)
. Am Psychiatr Assoc
. 2000
;157
(4 Suppl l
):1
–45
.8.
Depression in adults: treatment and management [Internet]
. London
: National Institute for Health and Care Excellence (NICE)
; 2022
[cited 2023 Nov 22]. (National Institute for Health and Care Excellence: Guidelines). Available from: http://www.ncbi.nlm.nih.gov/books/NBK583074/9.
Rush
AJ
, Trivedi
MH
, Wisniewski
SR
, Nierenberg
AA
, Stewart
JW
, Warden
D
, et al. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report
. Am J Psychiatry
. 2006
;163
(11
):1905
–17
. 10.
Whiteford
HA
, Harris
MG
, McKeon
G
, Baxter
A
, Pennell
C
, Barendregt
JJ
, et al. Estimating remission from untreated major depression: a systematic review and meta-analysis
. Psychol Med
. 2013
;43
(8
):1569
–85
. 11.
Li
H
, Cui
L
, Li
J
, Liu
Y
, Chen
Y
. Comparative efficacy and acceptability of neuromodulation procedures in the treatment of treatment-resistant depression: a network meta-analysis of randomized controlled trials
. J Affect Disord
. 2021
;287
:115
–24
. 12.
Voineskos
D
, Daskalakis
ZJ
, Blumberger
DM
. Management of treatment-resistant depression: challenges and strategies
. Neuropsychiatr Dis Treat
. 2020
;16
:221
–34
. 13.
Rossi
S
, Hallett
M
, Rossini
PM
, Pascual-Leone
A
, Safety of TMS Consensus Group
. Safety, ethical considerations, and application guidelines for the use of transcranial magnetic stimulation in clinical practice and research
. Clin Neurophysiol
. 2009
;120
(12
):2008
–39
. 14.
Dalhuisen
I
, van Bronswijk
S
, Bors
J
, Smit
F
, Spijker
J
, Tendolkar
I
, et al. The association between sample and treatment characteristics and the efficacy of repetitive transcranial magnetic stimulation in depression: a meta-analysis and meta-regression of sham-controlled trials
. Neurosci Biobehav Rev
. 2022
;141
:104848
. 15.
Fitzgerald
PB
, Fountain
S
, Daskalakis
ZJ
. A comprehensive review of the effects of rTMS on motor cortical excitability and inhibition
. Clin Neurophysiol
. 2006
;117
(12
):2584
–96
. 16.
Ridding
MC
, Rothwell
JC
. Is there a future for therapeutic use of transcranial magnetic stimulation
. Nat Rev Neurosci
. 2007
;8
(7
):559
–67
. 17.
Grimm
S
, Beck
J
, Schuepbach
D
, Hell
D
, Boesiger
P
, Bermpohl
F
, et al. Imbalance between left and right dorsolateral prefrontal cortex in major depression is linked to negative emotional judgment: an fMRI study in severe major depressive disorder
. Biol Psychiatry
. 2008
;63
(4
):369
–76
. 18.
Hecht
D
. Depression and the hyperactive right-hemisphere
. Neurosci Res
. 2010
;68
(2
):77
–87
. 19.
Jalinous
R
. Technical and practical aspects of magnetic nerve stimulation
. J Clin Neurophysiol
. 1991
;8
(1
):10
–25
. 20.
Berlim
MT
, van den Eynde
F
, Tovar-Perdomo
S
, Daskalakis
ZJ
. Response, remission and drop-out rates following high-frequency repetitive transcranial magnetic stimulation (rTMS) for treating major depression: a systematic review and meta-analysis of randomized, double-blind and sham-controlled trials
. Psychol Med
. 2014
;44
(2
):225
–39
. 21.
Brunoni
AR
, Chaimani
A
, Moffa
AH
, Razza
LB
, Gattaz
WF
, Daskalakis
ZJ
, et al. Repetitive transcranial magnetic stimulation for the acute treatment of major depressive episodes: a systematic review with network meta-analysis
. JAMA Psychiatry
. 2017
;74
(2
):143
–52
. 22.
George
MS
, Wassermann
EM
, Kimbrell
TA
, Little
JT
, Williams
WE
, Danielson
AL
, et al. Mood improvement following daily left prefrontal repetitive transcranial magnetic stimulation in patients with depression: a placebo-controlled crossover trial
. Am J Psychiatry
. 1997
;154
(12
):1752
–6
. 23.
Pascual-Leone
A
, Rubio
B
, Pallardó
F
, Catalá
MD
. Rapid-rate transcranial magnetic stimulation of left dorsolateral prefrontal cortex in drug-resistant depression
. Lancet
. 1996
;348
(9022
):233
–7
. 24.
Herwig
U
, Satrapi
P
, Schönfeldt-Lecuona
C
. Using the international 10-20 EEG system for positioning of transcranial magnetic stimulation
. Brain Topogr
. 2003
;16
(2
):95
–9
. 25.
Beam
W
, Borckardt
JJ
, Reeves
ST
, George
MS
. An efficient and accurate new method for locating the F3 position for prefrontal TMS applications
. Brain Stimul
. 2009
;2
(1
):50
–4
. 26.
Rusjan
PM
, Barr
MS
, Farzan
F
, Arenovich
T
, Maller
JJ
, Fitzgerald
PB
, et al. Optimal transcranial magnetic stimulation coil placement for targeting the dorsolateral prefrontal cortex using novel magnetic resonance image-guided neuronavigation
. Hum Brain Mapp
. 2010
;31
(11
):1643
–52
. 27.
Noh
TS
, Rah
YC
, Kyong
JS
, Kim
JS
, Park
MK
, Lee
JH
, et al. Comparison of treatment outcomes between 10 and 20 EEG electrode location system-guided and neuronavigation-guided repetitive transcranial magnetic stimulation in chronic tinnitus patients and target localization in the Asian brain
. Acta Otolaryngol
. 2017
;137
(9
):945
–51
. 28.
Kong
G
, Wei
L
, Wang
J
, Zhu
C
, Tang
Y
. The therapeutic potential of personalized connectivity-guided transcranial magnetic stimulation target over group-average target for depression
. Brain Stimul
. 2022
;15
(5
):1063
–4
. 29.
Relethford
JH
. Craniometric variation among modern human populations
. Am J Phys Anthropol
. 1994
;95
(1
):53
–62
. 30.
Wilkinson
C
. Forensic facial reconstruction [Internet]
. Cambridge University Press
; 2004
. [cited 2023 Nov 22]. 86 pp. Available from: https://books.google.co.jp/books?hl=ja&lr=lang_ja|lang_en&id=NKWm9Q0vbT4C&oi=fnd&pg=PP13&dq=Forensic+Facial+Reconstruction&ots=bBnMfYeXKN&sig=USV7xi9LagnvKTwtf3G2ZD_ovEQ31.
Herwig
U
, Padberg
F
, Unger
J
, Spitzer
M
, Schönfeldt-Lecuona
C
. Transcranial magnetic stimulation in therapy studies: examination of the reliability of “standard” coil positioning by neuronavigation
. Biol Psychiatry
. 2001
;50
(1
):58
–61
. 32.
Fitzgerald
PB
, Maller
JJ
, Hoy
KE
, Thomson
R
, Daskalakis
ZJ
. Exploring the optimal site for the localization of dorsolateral prefrontal cortex in brain stimulation experiments
. Brain Stimul
. 2009
;2
(4
):234
–7
. 33.
Fitzgerald
PB
, Hoy
K
, McQueen
S
, Maller
JJ
, Herring
S
, Segrave
R
, et al. A randomized trial of rTMS targeted with MRI based neuro-navigation in treatment-resistant depression
. Neuropsychopharmacology
. 2009
;34
(5
):1255
–62
. 34.
Hamilton
M
. A rating SCALE FOR DEPRESSION
. J Neurol Neurosurg Psychiatry
. 1960
;23
(1
):56
–62
. 35.
O’Reardon
JP
, Solvason
HB
, Janicak
PG
, Sampson
S
, Isenberg
KE
, Nahas
Z
, et al. Efficacy and safety of transcranial magnetic stimulation in the acute treatment of major depression: a multisite randomized controlled trial
. Biol Psychiatry
. 2007
;62
(11
):1208
–16
. 36.
Koizumi
K
, Ueda
K
, Li
Z
, Nakao
M
. Effects of transcranial direct current stimulation on brain networks related to creative thinking
. Front Hum Neurosci
. 2020
;14
:541052
. 37.
Benjamini
Y
, Hochberg
Y
. Controlling the false discovery rate: a practical and powerful approach to multiple testing
. J Roy Stat Soc B
. 1995
;57
(1
):289
–300
. 38.
Ahdab
R
, Ayache
SS
, Brugières
P
, Goujon
C
, Lefaucheur
JP
. Comparison of “standard” and “navigated” procedures of TMS coil positioning over motor, premotor and prefrontal targets in patients with chronic pain and depression
. Neurophysiol Clin
. 2010
;40
(1
):27
–36
. 39.
Mir-Moghtadaei
A
, Caballero
R
, Fried
P
, Fox
MD
, Lee
K
, Giacobbe
P
, et al. Concordance between BeamF3 and MRI-neuronavigated target sites for repetitive transcranial magnetic stimulation of the left dorsolateral prefrontal cortex
. Brain Stimul
. 2015
;8
(5
):965
–73
. 40.
Trapp
NT
, Bruss
J
, King Johnson
M
, Uitermarkt
BD
, Garrett
L
, Heinzerling
A
, et al. Reliability of targeting methods in TMS for depression: Beam F3 vs. 5.5 cm
. Brain Stimul
. 2020
;13
(3
):578
–81
. 41.
Hebel
T
, Göllnitz
A
, Schoisswohl
S
, Weber
FC
, Abdelnaim
M
, Wetter
TC
, et al. A direct comparison of neuronavigated and non-neuronavigated intermittent theta burst stimulation in the treatment of depression
. Brain Stimul
. 2021
;14
(2
):335
–43
. © 2024 S. Karger AG, Basel
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
2024
You do not currently have access to this content.
